Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Keratosis, Actinic 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Warts 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Radiodermatitis 1 Parapsoriasis 1 Non-Melanoma Skin Cancer (NMSC) 1 Neoplasms 1 Hypogonadism 1 Hemangioma, Cavernous 1 Hemangioma 1 Head and Neck Cancer Patients Treated With Radiotherapy 1 Fatigue 1 Exanthema 1 Eunuchism 1 Dermatitis, Contact 1 Carcinoma, Squamous Cell 1 Carcinoma, Basal Cell 1 Carcinoma 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Testosterone 3 trametinib 1 testosterone undecanoate 1 testosterone 17 beta-cypionate 1 sotorasib 1 selpercatinib 1 pembrolizumab 1 osimertinib 1 lorlatinib 1 dabrafenib 1 cemiplimab 1 brigatinib 1 alectinib 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Gonadotropin-Releasing Hormone 1 Gels 1 Drug Evaluation 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Eunuchism × Gels × Clear all

NCT04301765 2026-03-31

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡